JP2025501457A5 - - Google Patents
Info
- Publication number
- JP2025501457A5 JP2025501457A5 JP2024533884A JP2024533884A JP2025501457A5 JP 2025501457 A5 JP2025501457 A5 JP 2025501457A5 JP 2024533884 A JP2024533884 A JP 2024533884A JP 2024533884 A JP2024533884 A JP 2024533884A JP 2025501457 A5 JP2025501457 A5 JP 2025501457A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense oligonucleotide
- sequence
- splice modulator
- actl6b
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21212904.3 | 2021-12-07 | ||
| EP21212904 | 2021-12-07 | ||
| PCT/EP2022/084365 WO2023104693A1 (en) | 2021-12-07 | 2022-12-05 | Antisense oligonucleotides targeting actl6b |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501457A JP2025501457A (ja) | 2025-01-22 |
| JP2025501457A5 true JP2025501457A5 (enExample) | 2025-12-11 |
Family
ID=78824743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533884A Pending JP2025501457A (ja) | 2021-12-07 | 2022-12-05 | Ａｃｔｌ６ｂを標的とするアンチセンスオリゴヌクレオチド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240318180A1 (enExample) |
| EP (1) | EP4444882A1 (enExample) |
| JP (1) | JP2025501457A (enExample) |
| CN (1) | CN118434858A (enExample) |
| WO (1) | WO2023104693A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20250394A1 (es) * | 2022-05-18 | 2025-02-11 | Hoffmann La Roche | Oligonucleotidos mejorados que actuan sobre sitios de proteina de union a arn |
| WO2024126654A1 (en) * | 2022-12-14 | 2024-06-20 | F. Hoffmann-La Roche Ag | Antisense oligonucleotides targeting actl6b |
| CN122055620A (zh) * | 2023-09-29 | 2026-05-15 | 豪夫迈·罗氏有限公司 | 肽生物标志物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| EP1015469B2 (en) | 1997-09-12 | 2015-11-18 | Exiqon A/S | Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| BRPI0008131B8 (pt) | 1999-02-12 | 2021-05-25 | Daiichi Sankyo Co Ltd | composto ou um sal deste, análogo de oligonucleotídeo, composição farmacêutica, sonda para um gene,iniciador para começar a amplificação, uso de um análogo de oligonucleotídeo ou de um sal deste farmacologicamente aceitável, agente antisentido, e, agente antígeno |
| ATE356824T1 (de) | 1999-05-04 | 2007-04-15 | Santaris Pharma As | L-ribo-lna analoge |
| US6617442B1 (en) | 1999-09-30 | 2003-09-09 | Isis Pharmaceuticals, Inc. | Human Rnase H1 and oligonucleotide compositions thereof |
| EP2284269B1 (en) | 2002-11-18 | 2017-08-09 | Roche Innovation Center Copenhagen A/S | Antisense design |
| DE602007009487D1 (de) | 2006-01-27 | 2010-11-11 | Isis Pharmaceutical Inc | 6-modifizierte bicyclische nukleinsäureanaloga |
| US7666854B2 (en) | 2006-05-11 | 2010-02-23 | Isis Pharmaceuticals, Inc. | Bis-modified bicyclic nucleic acid analogs |
| CA2651453C (en) | 2006-05-11 | 2014-10-14 | Isis Pharmaceuticals, Inc. | 5'-modified bicyclic nucleic acid analogs |
| DK2170917T3 (da) | 2007-05-30 | 2012-10-08 | Isis Pharmaceuticals Inc | N-Substituerede bicycliske nukleinsyreanaloge med aminomethylenbro |
| WO2008154401A2 (en) | 2007-06-08 | 2008-12-18 | Isis Pharmaceuticals, Inc. | Carbocyclic bicyclic nucleic acid analogs |
| AU2008272918B2 (en) | 2007-07-05 | 2012-09-13 | Isis Pharmaceuticals, Inc. | 6-disubstituted bicyclic nucleic acid analogs |
| WO2009067647A1 (en) | 2007-11-21 | 2009-05-28 | Isis Pharmaceuticals, Inc. | Carbocyclic alpha-l-bicyclic nucleic acid analogs |
| WO2010036698A1 (en) | 2008-09-24 | 2010-04-01 | Isis Pharmaceuticals, Inc. | Substituted alpha-l-bicyclic nucleosides |
| EP2462153B1 (en) | 2009-08-06 | 2015-07-29 | Isis Pharmaceuticals, Inc. | Bicyclic cyclohexose nucleic acid analogs |
| US8846637B2 (en) | 2010-06-08 | 2014-09-30 | Isis Pharmaceuticals, Inc. | Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom |
| EP2850092B1 (en) | 2012-04-09 | 2017-03-01 | Ionis Pharmaceuticals, Inc. | Tricyclic nucleic acid analogs |
| CA2889044A1 (en) | 2012-11-15 | 2014-05-22 | Roche Innovation Center Copenhagen A/S | Anti apob antisense conjugate compounds |
| EP3052632A4 (en) * | 2013-10-04 | 2017-03-29 | Rana Therapeutics, Inc. | Compositions and methods for treating amyotrophic lateral sclerosis |
| US10358643B2 (en) | 2014-01-30 | 2019-07-23 | Hoffmann-La Roche, Inc. | Poly oligomer compound with biocleavable conjugates |
| JP7036723B2 (ja) * | 2015-12-14 | 2022-03-15 | コールド スプリング ハーバー ラボラトリー | 眼疾患の処置のための組成物および方法 |
| WO2017106382A1 (en) * | 2015-12-14 | 2017-06-22 | Cold Spring Harbor Laboratory | Compositions and methods for treatment of central nervous system diseases |
-
2022
- 2022-12-05 CN CN202280080863.7A patent/CN118434858A/zh active Pending
- 2022-12-05 JP JP2024533884A patent/JP2025501457A/ja active Pending
- 2022-12-05 EP EP22830207.1A patent/EP4444882A1/en active Pending
- 2022-12-05 WO PCT/EP2022/084365 patent/WO2023104693A1/en not_active Ceased
-
2024
- 2024-06-06 US US18/735,668 patent/US20240318180A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025500335A5 (enExample) | ||
| US10369232B2 (en) | Allele selective gene editing and uses thereof | |
| US20220090084A1 (en) | Antisense-induced exon exclusion in myostatin | |
| US20240327845A1 (en) | Antisense oligonucleotides targeting unc13a | |
| CN119654412A (zh) | 激活补体因子h表达的寡核苷酸调节剂 | |
| US20240318180A1 (en) | Antisense oligonucleotides targeting actl6b | |
| KR20200104347A (ko) | 포스포로디티오에이트 인터뉴클레오시드 연결을 포함하는 갭머 올리고뉴클레오티드 | |
| US11911403B2 (en) | Antisense-induced exon exclusion in type VII collagen | |
| TW202102676A (zh) | 調節atxn2表現之寡核苷酸 | |
| KR20220145865A (ko) | 엑손 51의 스키핑을 유도하는 안티센스 핵산 | |
| JP2026074094A (ja) | Ｆｕｂｐ１発現を調節するための増強されたオリゴヌクレオチド | |
| US20230002762A1 (en) | Oligonucleotides comprising a phosphorodithioate internucleoside linkage | |
| TW202329983A (zh) | Ｒｎａ編輯 | |
| US20250051772A1 (en) | Antisense Oligonucleotide for Targeting Progranulin | |
| JP2025518522A5 (enExample) | ||
| AU2023270744A1 (en) | Improved oligonucleotides targeting rna binding protein sites | |
| WO2022018155A1 (en) | Lna oligonucleotides for splice modulation of stmn2 | |
| CN115698290A (zh) | 用于治疗神经系统疾病的补体组分4抑制剂以及使用它们的相关组合物、系统和方法 | |
| US20260132403A2 (en) | Antisense oligonucleotides for targeting progranulin | |
| HK40106800A (en) | Antisense oligonucleotides targeting actl6b | |
| HK40111667A (en) | Antisense oligonucleotides targeting unc13a | |
| US20220403388A1 (en) | Oligonucleotide Progranulin Agonists | |
| US20230212572A1 (en) | Guanosine Analogues for Use in Therapeutics Polynucleotides | |
| HK40114073A (en) | Antisense oligonucleotides targeting cfp-elk1 intergene region | |
| WO2024126654A1 (en) | Antisense oligonucleotides targeting actl6b |